Why is Boston Bio falling/rising?

As of 15-Sep, Boston Bio Systems Ltd's stock price is currently at 8.05, reflecting an increase of 0.2, or 2.55%. The stock has shown a trend reversal, gaining after two consecutive days of decline. Notably, it has outperformed its sector by 3.78% today. The delivery volume on September 12 has surged by 281.24% compared to the 5-day average, indicating rising investor participation. While the stock's performance over the past week shows a decline of 5.29%, it has increased by 1.90% over the past month, suggesting some recovery. The stock is currently trading above its 50-day and 100-day moving averages but below its 5-day, 20-day, and 200-day moving averages, which may indicate mixed short-term momentum.
In the broader market context, the Sensex has gained 1.24% over the past week and 1.47% over the past month, suggesting that while Boston Bio has struggled in the short term, it has managed to recover somewhat in the longer term. The stock's recent performance contrasts with the benchmark, highlighting its underperformance over the past week despite the positive movement today. Overall, the increase in investor participation and the stock's ability to reverse its recent downward trend are contributing factors to its current rise, even as it continues to lag behind the broader market in the short term.